Bio-Rad Laboratories Inc (BIO)
293.85
-1.88
(-0.64%)
USD |
NYSE |
May 17, 16:00
293.96
+0.11
(+0.04%)
Pre-Market: 20:00
Bio-Rad Laboratories Gross Profit Margin (Quarterly): 53.37% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 53.37% |
December 31, 2023 | 53.78% |
September 30, 2023 | 53.10% |
June 30, 2023 | 53.22% |
March 31, 2023 | 53.55% |
December 31, 2022 | 54.38% |
September 30, 2022 | 54.72% |
June 30, 2022 | 57.16% |
March 31, 2022 | 57.51% |
December 31, 2021 | 54.37% |
September 30, 2021 | 58.56% |
June 30, 2021 | 56.09% |
March 31, 2021 | 55.12% |
December 31, 2020 | 58.27% |
September 30, 2020 | 56.75% |
June 30, 2020 | 54.57% |
March 31, 2020 | 55.52% |
December 31, 2019 | 52.92% |
September 30, 2019 | 54.76% |
June 30, 2019 | 53.75% |
March 31, 2019 | 56.28% |
December 31, 2018 | 53.91% |
September 30, 2018 | 52.60% |
June 30, 2018 | 52.38% |
March 31, 2018 | 54.79% |
Date | Value |
---|---|
December 31, 2017 | 55.57% |
September 30, 2017 | 55.98% |
June 30, 2017 | 54.17% |
March 31, 2017 | 54.01% |
December 31, 2016 | 55.07% |
September 30, 2016 | 54.93% |
June 30, 2016 | 54.23% |
March 31, 2016 | 56.03% |
December 31, 2015 | 54.07% |
September 30, 2015 | 56.06% |
June 30, 2015 | 55.25% |
March 31, 2015 | 57.13% |
December 31, 2014 | 53.06% |
September 30, 2014 | 54.38% |
June 30, 2014 | 55.37% |
March 31, 2014 | 54.05% |
December 31, 2013 | 53.56% |
September 30, 2013 | 56.27% |
June 30, 2013 | 57.13% |
March 31, 2013 | 54.32% |
December 31, 2012 | 54.81% |
September 30, 2012 | 54.90% |
June 30, 2012 | 56.40% |
March 31, 2012 | 57.29% |
December 31, 2011 | 56.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
52.92%
Minimum
Dec 2019
58.56%
Maximum
Sep 2021
55.07%
Average
54.65%
Median
Gross Profit Margin (Quarterly) Benchmarks
Agilent Technologies Inc | 54.76% |
Azenta Inc | 39.83% |
Harvard Bioscience Inc | 60.26% |
Bionano Genomics Inc | 32.20% |
Akoya Biosciences Inc | 45.66% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -3.63% |
Return on Assets | -2.58% |
Return on Invested Capital | -3.20% |
Profit Margin (Quarterly) | 62.85% |
Operating Margin (Quarterly) | 7.32% |
Return on Net Operating Assets | -11.45% |